Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikos Maniadakis

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Vascular Health and Risk Management|October 15, 2013
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartanFotini Gialama, Nikos Maniadakis
Pharmacoeconomics|August 2, 2014
Cost effectiveness of treatments for non-ST-segment elevation acute coronary syndromeFotini Gialama, Evangelia Miloni, Nikos Maniadakis
BMC Cardiovascular Disorders|April 16, 2011
Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone surveyNikos Maniadakis, Georgia Kourlaba, Vasileios Fragoulakis
Applied Health Economics and Health Policy|August 3, 2012
Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for GreeceGeorgia Kourlaba, Vassilis Fragoulakis, Nikos Maniadakis
Applied Health Economics and Health Policy|June 7, 2012
Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysisGeorgia Kourlaba, Vassilis Fragoulakis, Nikos Maniadakis
Applied Health Economics and Health Policy|November 19, 2013
The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluationsFotini Gialama, Panagiotis Prezerakos, Nikos Maniadakis
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|August 6, 2013
Economic evaluation of dabigatran etexilate in the management of atrial fibrillation in GreeceGeorge K Andrikopoulos, Vasilis Fragoulakis, Nikos Maniadakis
International Journal of Cardiology|March 20, 2016
A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectorisKaterina Vellopoulou, Georgia Kourlaba, Nikos Maniadakis, et al.
Applied Health Economics and Health Policy|October 18, 2018
The Economic Burden of Chronic Obstructive Pulmonary Disease in GreeceGeorgia Kourlaba, Georgios Hillas, Theodoros Vassilakopoulos, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 28, 2016
The disease burden of chronic obstructive pulmonary disease in GreeceGeorgia Kourlaba, Georgios Hillas, Theodoros Vassilakopoulos, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Vascular Health and Risk Management|October 15, 2013
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartanFotini Gialama, Nikos Maniadakis
Pharmacoeconomics|August 2, 2014
Cost effectiveness of treatments for non-ST-segment elevation acute coronary syndromeFotini Gialama, Evangelia Miloni, Nikos Maniadakis
BMC Cardiovascular Disorders|April 16, 2011
Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone surveyNikos Maniadakis, Georgia Kourlaba, Vasileios Fragoulakis
Applied Health Economics and Health Policy|August 3, 2012
Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for GreeceGeorgia Kourlaba, Vassilis Fragoulakis, Nikos Maniadakis
Applied Health Economics and Health Policy|June 7, 2012
Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysisGeorgia Kourlaba, Vassilis Fragoulakis, Nikos Maniadakis
Applied Health Economics and Health Policy|November 19, 2013
The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluationsFotini Gialama, Panagiotis Prezerakos, Nikos Maniadakis
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|August 6, 2013
Economic evaluation of dabigatran etexilate in the management of atrial fibrillation in GreeceGeorge K Andrikopoulos, Vasilis Fragoulakis, Nikos Maniadakis
International Journal of Cardiology|March 20, 2016
A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectorisKaterina Vellopoulou, Georgia Kourlaba, Nikos Maniadakis, et al.
Applied Health Economics and Health Policy|October 18, 2018
The Economic Burden of Chronic Obstructive Pulmonary Disease in GreeceGeorgia Kourlaba, Georgios Hillas, Theodoros Vassilakopoulos, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 28, 2016
The disease burden of chronic obstructive pulmonary disease in GreeceGeorgia Kourlaba, Georgios Hillas, Theodoros Vassilakopoulos, et al.
Pageof 7